Zimmer Holdings (NYSE:ZMH) had its price objective raised by Canaccord Genuity from $88.50 to $94.00 in a research report released on Friday morning, Stock Ratings Network reports. Canaccord Genuity currently has a buy rating on the stock.
Canaccord Genuity has also modified their ratings on a number of other healthcare stocks in the few days. The firm raised its price target on shares of NxStage Medical Inc. from $16.50 to $17.00. They have a buy rating on that stock. Also, Canaccord Genuity raised its price target on shares of Meridian Bioscience Inc. from $20.00 to $25.00. They have a hold rating on that stock. Finally, Canaccord Genuity raised its price target on shares of Abaxis Inc. from $37.00 to $40.00. They have a hold rating on that stock.
ZMH has been the subject of a number of other recent research reports. Analysts at BMO Capital Markets raised their price target on shares of Zimmer Holdings from $80.00 to $91.00 in a research note to investors on Friday. They now have an outperform rating on the stock. Separately, analysts at Barclays Capital raised their price target on shares of Zimmer Holdings from $87.00 to $90.00 in a research note to investors on Friday. They now have an overweight rating on the stock. Finally, analysts at Credit Suisse raised their price target on shares of Zimmer Holdings from $80.00 to $90.00 in a research note to investors on Tuesday, July 23rd. They now have a neutral rating on the stock.
Two research analysts have rated the stock with a sell rating, fifteen have given a hold rating and nine have assigned a buy rating to the company. The stock has a consensus rating of Hold and a consensus target price of $81.04.
Shares of Zimmer Holdings (NYSE:ZMH) traded down 0.75% during mid-day trading on Friday, hitting $82.99. Zimmer Holdings has a one year low of $57.60 and a one year high of $85.08. The stock’s 50-day moving average is currently $78.76. The company has a market cap of $14.009 billion and a P/E ratio of 20.58.
In other Zimmer Holdings news, Insider Jeffery A. Mccaulley dumped 112,255 shares of Zimmer Holdings stock on the open market in a transaction that occured on Monday, July 29th. The shares were sold at an average price of $83.40, for a total value of $9,362,067.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Zimmer Holdings, Inc (NYSE:ZMH) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.